8-K

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549




                                    FORM 8-K

                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



       Date of Report (Date of earliest event reported): February 27, 2003



                          BRISTOL-MYERS SQUIBB COMPANY
             (Exact Name of Registrant as Specified in its Charter)





             Delaware                1-1136                   22-079-0350
          (State or Other       (Commission File             (IRS Employer
         Jurisdiction of             Number)                Identification
          Incorporation)                                        Number)


                                 345 Park Avenue
                               New York, NY, 10154
                     (Address of Principal Executive Office)

       Registrant's telephone number, including area code: (212) 546-4000





================================================================================






ITEM 5. OTHER EVENTS.

         On February 27, 2003, the Registrant announced in a press release that
it expects to release the results of the previously disclosed restatement of its
financial statements on Monday, March 10, 2003. The Registrant also announced
that it expects to file its amended 2001 Form 10-K and its third quarter 2002
10-Q on March 10, 2003. Incorporated herein by reference is the press release
issued by the Registrant on February 27, 2003 attached hereto as Exhibit 99.1.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

        (a)  Financial Statements of Business to be Acquired:  Not Applicable.

         (b) Pro Forma Financial Information: Not Applicable.

         (c) Exhibits


        EXHIBIT NO.          DESCRIPTION
        -----------          -----------

           99.1              Press Release dated February 27, 2003









                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.

                                      Bristol-Myers Squibb Company,



                                      By:    /s/ SANDRA LEUNG
                                            --------------------------
                                      Name:     Sandra Leung
                                      Title:    Secretary


         Date:  March 4, 2003






                                  EXHIBIT INDEX


                 EXHIBIT NO.          DESCRIPTION
                 -----------          -----------

                    99.1              Press Release dated February 27, 2003

EX-99.1

                                                                    EXHIBIT 99.1
[LOGO OF BRISTOL-MYERS SQUIBB COMPANY]

 CONTACT:             Bob Laverty                    John Elicker
                      Corporate Affairs              Investor Relations
                      (609) 252-5732                 (212) 546-3775
                      bob.laverty@bms.com            john.elicker@bms.com


           BRISTOL-MYERS SQUIBB TO ANNOUNCE RESULTS OF RESTATEMENT AND
                         2002 EARNINGS ON MARCH 10, 2003

         NEW YORK, N.Y. (February 27, 2003) -- Bristol-Myers Squibb Company
(NYSE: BMY) today announced that it expects to release the results of the
previously disclosed restatement of its financial statements on Monday, March
10, 2003. The company also expects to announce full year 2002 earnings on the
same day.

         The company also stated that it expects to file its amended 2001 Form
10-K and its third quarter 2002 10-Q on March 10, 2003. The company expects
that its 2002 10-K, which is required to be filed on March 31, 2003, will be
filed on time.

         A conference call will be held on March 10 at 8 a.m. (EDT). Financial
information will be reviewed and company executives will address inquiries from
investors and analysts. Investors and the general public are invited to listen
to a live webcast of the call at www.bms.com/ir or by dialing (913) 981-5510. A
replay of the call will be available on March 10 beginning at 11:30 a.m. through
8 p.m. on March 31. You may access the replay at www.bms.com/ir or by dialing
(402) 280-9013.

         Bristol-Myers Squibb Company is a global pharmaceutical and related
health care products company whose mission is to extend and enhance human
life.

                                       ###